Trials / Conditions / Stage IV (Metastatic) Breast Cancer
Stage IV (Metastatic) Breast Cancer
3 registered clinical trials studyying Stage IV (Metastatic) Breast Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, NCT07163481 | Hunan Cancer Hospital | Phase 1 |
| Withdrawn | Fulvestrant + Neratinib In Breast Cancer NCT04901299 | Massachusetts General Hospital | Phase 2 |
| Terminated | A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastati NCT00140140 | Celgene | Phase 1 / Phase 2 |